AU7559200A - Hypertriglyceridemia remedies and antiobestics - Google Patents

Hypertriglyceridemia remedies and antiobestics

Info

Publication number
AU7559200A
AU7559200A AU75592/00A AU7559200A AU7559200A AU 7559200 A AU7559200 A AU 7559200A AU 75592/00 A AU75592/00 A AU 75592/00A AU 7559200 A AU7559200 A AU 7559200A AU 7559200 A AU7559200 A AU 7559200A
Authority
AU
Australia
Prior art keywords
antiobestics
hypertriglyceridemia
remedies
hypertriglyceridemia remedies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU75592/00A
Inventor
Hiromasa Hashimoto
Naoya Odani
Shinji Yata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Tobacco Inc
Original Assignee
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc
Publication of AU7559200A publication Critical patent/AU7559200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
AU75592/00A 1999-10-12 2000-10-06 Hypertriglyceridemia remedies and antiobestics Abandoned AU7559200A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP28944799 1999-10-12
JP11/289447 1999-10-12
JP11/365720 1999-12-24
JP36572099 1999-12-24
PCT/JP2000/007016 WO2001027094A1 (en) 1999-10-12 2000-10-06 Hypertriglyceridemia remedies and antiobestics

Publications (1)

Publication Number Publication Date
AU7559200A true AU7559200A (en) 2001-04-23

Family

ID=26557603

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75592/00A Abandoned AU7559200A (en) 1999-10-12 2000-10-06 Hypertriglyceridemia remedies and antiobestics

Country Status (3)

Country Link
AU (1) AU7559200A (en)
PE (1) PE20011002A1 (en)
WO (1) WO2001027094A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR045651A1 (en) * 2003-09-19 2005-11-02 Solvay Pharm Bv THIAZOL DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS
TW200806641A (en) 2006-01-25 2008-02-01 Synta Pharmaceuticals Corp Substituted aromatic compounds for inflammation and immune-related uses
CA2691309A1 (en) 2007-06-14 2008-12-24 Amgen Inc. Tricyclic inhibitors of hydroxysteroid dehydrogenases
WO2009123164A1 (en) * 2008-04-02 2009-10-08 塩野義製薬株式会社 Heterocyclic derivative having inhibitory activity on endothelial lipase
EP2135864A1 (en) * 2008-06-16 2009-12-23 Faes Farma, S.A. 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases
TWI403506B (en) * 2008-06-16 2013-08-01 Faes Farma Sa 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4632930A (en) * 1984-11-30 1986-12-30 E. I. Du Pont De Nemours And Company Antihypertensive alkyl-arylimidazole, thiazole and oxazole derivatives
US5451677A (en) * 1993-02-09 1995-09-19 Merck & Co., Inc. Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
EP0772606A1 (en) * 1994-07-27 1997-05-14 G.D. SEARLE & CO. Substituted thiazoles for the treatment of inflammation
IL118474A (en) * 1995-06-01 2001-08-08 Sankyo Co Benzimidazole derivatives and pharmaceutical compositions containing the same
EP1027050B1 (en) * 1997-10-27 2004-01-14 Takeda Chemical Industries, Ltd. 1,3-thiazoles as adenosine a3 receptor antagonists for the treatment of allergy, asthma and diabetes

Also Published As

Publication number Publication date
WO2001027094A1 (en) 2001-04-19
PE20011002A1 (en) 2001-10-01

Similar Documents

Publication Publication Date Title
AU3620600A (en) Skin-marking devices and their use
AU2001246876A1 (en) Remedies
AU2001246877A1 (en) Remedies
AU5259100A (en) Medicament
AU3731600A (en) Composition and structures made therefrom
HK1040995A1 (en) 2-oxoquinoline compounds and medicinal uses thereof
AU5020400A (en) Heteroaryloxypyrimidine insecticides and acaricides
AU7989400A (en) Compounds and methods
AU3215500A (en) Compounds and methods
AU1812001A (en) Cotton transcription factors and their uses
AU6605900A (en) Novel angiopoietin materials and methods
AU3837300A (en) Remedies
AU4923200A (en) Isothiazolecarboxamides and their use as microbicides
AU6635800A (en) Pyridomorphinans, thienomoprhinans and use thereof
AU3175900A (en) Tampon
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AUPQ342599A0 (en) Conjugates and uses thereof
AU2841801A (en) Triazolotriazinones and the use thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU1152601A (en) Compositions and their use
AU1626101A (en) Human transcriptomes
AU7559200A (en) Hypertriglyceridemia remedies and antiobestics
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof
AU3357700A (en) Phenoxypyrimidine insecticides and acaricides
AU4755600A (en) Benzohetero cyclylcyclo hexenones and their use as herbicides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase